News Archive

Dualsystems Biotech Announces Profiling Service for Reducing Drug Development Time and Overall Development Costs 28 Jan 2010: A fee-based drug profiling service designed to characterize the mechanism of action and identify off-target effects and novel targets for drugs under development is now available from Dualsystems Biotech AG. This early in-depth profiling of drug candidates helps shorten development time, lowers overall development costs, and results in drugs with a better safety profiles. Dualsystems Biotech AG

Supplier details

Dualsystems Biotech AG
Dualsystems Biotech AG, Grabenstrasse 11a, Schlieren CH-8952, Switzerland. Switzerland
T:	+41 (0)44 738 50 05
	more details
	Send email
	Company website
	Supplier news archive